NO812401L - Nye halogenfenyl-pyridyl-allylaminderivater. - Google Patents
Nye halogenfenyl-pyridyl-allylaminderivater.Info
- Publication number
- NO812401L NO812401L NO812401A NO812401A NO812401L NO 812401 L NO812401 L NO 812401L NO 812401 A NO812401 A NO 812401A NO 812401 A NO812401 A NO 812401A NO 812401 L NO812401 L NO 812401L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- formula
- pyridyl
- group
- allylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/48—Aldehydo radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7909514A SE7909514L (sv) | 1979-11-16 | 1979-11-16 | Nya halofenyl-pyridyl-allylaminderivat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO812401L true NO812401L (no) | 1981-07-13 |
Family
ID=20339337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO812401A NO812401L (no) | 1979-11-16 | 1981-07-13 | Nye halogenfenyl-pyridyl-allylaminderivater. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4418065A (es) |
| EP (2) | EP0029420A1 (es) |
| JP (1) | JPS56501524A (es) |
| AU (1) | AU538087B2 (es) |
| CA (1) | CA1155128A (es) |
| DK (1) | DK300781A (es) |
| ES (5) | ES8204721A1 (es) |
| FI (1) | FI812196A7 (es) |
| GR (1) | GR72129B (es) |
| NO (1) | NO812401L (es) |
| NZ (1) | NZ195558A (es) |
| PL (3) | PL129370B1 (es) |
| PT (1) | PT72066B (es) |
| SE (1) | SE7909514L (es) |
| SU (4) | SU1103794A3 (es) |
| WO (1) | WO1981001407A1 (es) |
| ZA (1) | ZA807102B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1150269A (en) * | 1980-11-14 | 1983-07-19 | Carl B. J. Ulff | Process for preparing 3-(4-bromophenyl)-3-(3-pyridyl)-allylamines |
| US4610995A (en) * | 1984-07-27 | 1986-09-09 | Coker Geoffrey G | Certain 1,1-diaryl-propenyl-3-(1-pyrrolidino-2-carboxylic acids, derivatives thereof and their anti-histaminic properties |
| GB8814639D0 (en) * | 1988-06-20 | 1988-07-27 | Ici Plc | Heterocyclic tertiary alcohol derivatives |
| US6503926B2 (en) * | 1998-09-04 | 2003-01-07 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6288083B1 (en) | 1998-09-04 | 2001-09-11 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| GB0219154D0 (en) * | 2002-08-16 | 2002-09-25 | Pfizer Ltd | Diaryl compounds |
| US6800652B2 (en) | 2002-08-16 | 2004-10-05 | Pfizer Inc. | Diaryl compounds |
| WO2015067923A1 (en) | 2013-11-05 | 2015-05-14 | Astrazeneca Ab | Nmda antagonist prodrugs |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2676964A (en) * | 1950-06-07 | 1954-04-27 | Schering Corp | 3-pyridyl propylamine antihistamine substances |
| DE966534C (de) | 1951-03-22 | 1957-08-22 | Schering Corp | Verfahren zur Herstellung von basisch substituierten Pyridinverbindungen |
| GB850298A (en) | 1956-10-30 | 1960-10-05 | Maggioni & C Societa Per Azion | ª‡,ª‡[(p-chlorophenyl)-(4-pyridyl)] carbinols and method of preparing same |
| DE1468359A1 (de) * | 1963-10-23 | 1968-11-28 | Merck & Co Inc | Verfahren zur Herstellung von Dibenzocycloheptehderivaten |
| US3396224A (en) * | 1965-09-09 | 1968-08-06 | Lilly Co Eli | Controlling phytopathogenic fungi on plants with 3-pyridyl methane derivatives |
| US3423510A (en) * | 1966-08-31 | 1969-01-21 | Geigy Chem Corp | 3-(p-halophenyl) - 3 - (2'-pyridyl-n-methylpropylamine for the treatment of depression |
| US3471505A (en) * | 1967-02-01 | 1969-10-07 | Ciba Geigy Corp | 1-(alkoxyphenyl)-1-(3-pyridyl)-carbinols |
| SE361663B (es) * | 1971-04-28 | 1973-11-12 | Haessle Ab | |
| US3928369A (en) * | 1971-04-28 | 1975-12-23 | Haessle Ab | Compounds useful as antidepressive agents, and a process for their preparation |
| US3928613A (en) * | 1971-04-28 | 1975-12-23 | Haessle Ab | Compounds useful as antidepressive agents |
| SE373850B (es) | 1972-11-16 | 1975-02-17 | Haessle Ab | |
| US4094908A (en) * | 1973-08-15 | 1978-06-13 | Richter Gedeon Vegyeszeti Gyar Rt. | Alpha-substituted benzhydrol derivatives |
| GB1480593A (en) * | 1973-11-30 | 1977-07-20 | Kefalas As | Xanthene and thioxanthene derivatives having pharmaceutical activity |
| US4186202A (en) * | 1974-11-21 | 1980-01-29 | Astra Lakemedel Aktiebolag | Phenyl-pyridylamine derivatives |
| SE388854B (sv) | 1974-11-21 | 1979-03-26 | Astra Laekemedel Ab | Forfarande for framstellning av fenylpyridylaminderivat |
| US4102887A (en) * | 1974-11-21 | 1978-07-25 | Per Arvid Emil Carlsson | Intermediates used in the preparation of phenyl-pyridylamine derivatives |
| SE418291B (sv) * | 1976-05-17 | 1981-05-18 | Astra Laekemedel Ab | 4-bromfenyl-3-pyridylderivat som mellanprodukter vid framstellning av fenylpyridylaminer |
| SE409706B (sv) | 1976-05-21 | 1979-09-03 | Astra Pharma Prod | Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat |
| SE418399B (sv) * | 1976-05-21 | 1981-05-25 | Astra Laekemedel Ab | Forfarande for framstellning av n,n-dimetyl-3-(4 bromfenyl)-3-(3-pyridyl)allylamin |
| SE409860B (sv) * | 1977-07-04 | 1979-09-10 | Astra Laekemedel Ab | En ny mellanprodukt for framstellning av terapeutiskt aktiva pyridinforeningar |
| SE409861B (sv) | 1977-07-04 | 1979-09-10 | Astra Laekemedel Ab | Ett nytt forfarande for framstellning av en terapeutisk aktiv pyridinforening |
| IE47628B1 (en) * | 1977-07-04 | 1984-05-16 | Astra Laekemedel Ab | Substituted aralkyl amines and amino-aryl alkenes having therapeutic activity |
-
1979
- 1979-11-16 SE SE7909514A patent/SE7909514L/xx not_active Application Discontinuation
-
1980
- 1980-11-14 CA CA000364712A patent/CA1155128A/en not_active Expired
- 1980-11-14 GR GR63358A patent/GR72129B/el unknown
- 1980-11-14 EP EP80850172A patent/EP0029420A1/en not_active Withdrawn
- 1980-11-14 NZ NZ195558A patent/NZ195558A/en unknown
- 1980-11-14 PL PL1980232731A patent/PL129370B1/pl unknown
- 1980-11-14 PT PT72066A patent/PT72066B/pt unknown
- 1980-11-14 ES ES496859A patent/ES8204721A1/es not_active Expired
- 1980-11-14 EP EP83200107A patent/EP0081478A3/en not_active Withdrawn
- 1980-11-14 AU AU64378/80A patent/AU538087B2/en not_active Ceased
- 1980-11-14 FI FI812196A patent/FI812196A7/fi not_active Application Discontinuation
- 1980-11-14 ZA ZA00807102A patent/ZA807102B/xx unknown
- 1980-11-14 US US06/232,043 patent/US4418065A/en not_active Expired - Fee Related
- 1980-11-14 PL PL1980227849A patent/PL128457B1/pl unknown
- 1980-11-14 WO PCT/SE1980/000286 patent/WO1981001407A1/en not_active Ceased
- 1980-11-14 JP JP50260380A patent/JPS56501524A/ja active Pending
- 1980-11-14 PL PL1980232732A patent/PL129369B1/pl unknown
-
1981
- 1981-07-07 DK DK300781A patent/DK300781A/da not_active Application Discontinuation
- 1981-07-13 NO NO812401A patent/NO812401L/no unknown
- 1981-07-15 SU SU813306852A patent/SU1103794A3/ru active
- 1981-12-16 ES ES508065A patent/ES8300097A1/es not_active Expired
- 1981-12-16 ES ES508062A patent/ES508062A0/es active Granted
- 1981-12-16 ES ES508064A patent/ES8300096A1/es not_active Expired
- 1981-12-16 ES ES508063A patent/ES8300095A1/es not_active Expired
-
1982
- 1982-04-13 SU SU823419749A patent/SU1149874A3/ru active
- 1982-04-13 SU SU823419750A patent/SU1149875A3/ru active
- 1982-12-30 SU SU823530055A patent/SU1138021A3/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW210339B (es) | ||
| TWI507195B (zh) | σ-受體抑制劑 | |
| NO174390B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinyl-methyl-substituerte aromater og heteroaromater | |
| TW200400816A (en) | Tricyclic steroid hormone nuclear receptor modulators | |
| NO147243B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater. | |
| SK56994A3 (en) | 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents | |
| NO812401L (no) | Nye halogenfenyl-pyridyl-allylaminderivater. | |
| NO301008B1 (no) | Metanoantracenforbindelser og farmasöytiske preparater inneholdende dem | |
| TW200819433A (en) | Quinoline derivatives I | |
| CN106831632B (zh) | 一种4h-3,1-苯并噁嗪类化合物催化氧化合成方法 | |
| US4736037A (en) | 2-halo-aryl-pyridinemethanols with analgesic or antiinflammatory activity | |
| Hoegberg et al. | Synthesis of pyridylallylamines related to zimelidine and their inhibition of neuronal monoamine uptake | |
| JPS6046115B2 (ja) | テトラヒドロピリジン及びピペリジン誘導体の製法 | |
| NO176357B (no) | Analogifremgangsmåte for fremstilling av 4,5,7,8-tetrahydro-6H-tiazolo [5,4-dÅ- azepiner | |
| Majumdar et al. | Palladium-mediated reductive Mizoroki–Heck cyclization strategy for the regioselective formation of dibenzoazocinone framework | |
| CA2071398A1 (en) | Aminomethyl-substituted 2,3-dihydropyrano/2,3-b/pyridines, process for their preparation and their use in medicaments | |
| US6043371A (en) | Organic compound synthesis | |
| EP0000322B1 (en) | Compounds having an anti-depressive or tranquilizing activity, pharmaceutical compositions containing them, and processes and intermediates for their preparation | |
| Kumar et al. | An efficient synthesis of 2-(1-methyl-1, 2, 5, 6-tetrahydropyridin-3-yl) morpholine: a potent M1 selective muscarinic agonist | |
| CA1056834A (en) | 3-(4-bromophenyl)-n-methyl-3-(3-pyridyl)-allylamine | |
| US3436391A (en) | Dihydroanthracene compounds | |
| NO860048L (no) | Octahydroindolizin-forbindelser med analgetisk virkning. | |
| Norton et al. | The Synthesis of Some Substituted 8-Aminoquinolines1 | |
| NO862494L (no) | Fremgangsmaate for fremstilling av nye aromatiske forbindelser. | |
| CZ2002499A3 (cs) | Derivát piperidinalkoholu, způsob jeho přípravy, jeho pouľití a farmaceutický prostředek, který ho obsahuje |